U.S. Capital Markets Stock News

NYSE:CNX
NYSE:CNXOil and Gas

CNX Resources Refines Gas Growth Plan And Cash Flow Resilience

CNX Resources (NYSE:CNX) is expanding its Utica development and updating its long-term Marcellus plan to align with rising in-basin demand from large-scale power and data center projects. The company has completed a major refinancing of long-term notes and finalized the conversion of its remaining convertible notes, changing the structure of its balance sheet. CNX has also added to its long-dated hedging program, seeking to manage exposure to natural gas price differentials over an extended...
OTCPK:ALPI.B
OTCPK:ALPI.BBanks

Alpine Banks Of Colorado (OTCPK:ALPI.B) Margin Improvement Challenges Cautious Earnings Narrative

Alpine Banks of Colorado (ALPI.B) opened Q1 2026 earnings season with Q4 2025 revenue of US$73.3 million and basic EPS of US$1.23, supported by quarterly net income of US$19.8 million. Over the past six reported quarters, revenue has ranged from US$59.2 million to US$73.3 million while basic EPS has moved between US$0.74 and US$1.73. This gives a clear view of how the top line and EPS have tracked together across 2024 and 2025. With trailing net profit margin at 25.9% versus 21.2% a year...
NasdaqGS:INSM
NasdaqGS:INSMBiotechs

Is It Time To Reassess Insmed (INSM) After The Recent Share Price Pullback

Wondering whether Insmed at US$133.26 is offering fair value or stretching expectations? This article walks through how the current price stacks up against several valuation yardsticks. The stock has had a mixed run recently, with a 1.4% decline over the last 7 days, an 18.0% decline over 30 days, and a 24.8% decline year to date, set against an 84.3% return over the past year and a very large return over three years. These moves sit against a backdrop of ongoing interest in the biotech...
NYSE:AIT
NYSE:AITTrade Distributors

Applied Industrial Technologies Buyback Raises Questions On Valuation And Insider Selling

Applied Industrial Technologies (NYSE:AIT) announced a new share repurchase program. The authorization covers the buyback of up to 3,000,000 shares. Applied Industrial Technologies focuses on industrial distribution and related services, supplying components and solutions to a wide range of end markets. Share repurchase authorizations of this size can matter for investors who watch how companies balance cash uses between growth, acquisitions, dividends, and buybacks. For you as a...
NasdaqGS:ICHR
NasdaqGS:ICHRSemiconductor

Is It Too Late To Consider Ichor Holdings (ICHR) After A 216% Yearly Surge?

Investors may be wondering if Ichor Holdings at around US$64.42 is still offering value, or if most of the opportunity is already priced in. The stock has seen a 33.9% gain over the last 30 days and a 215.6% return year to date, with 206.9% over the past year and 126.1% over three years. These figures can change how investors view both its potential and its risks. Recent attention on semiconductor related names, including Ichor Holdings, has highlighted themes such as supply chain...
NYSE:MTRN
NYSE:MTRNMetals and Mining

How Record Backlog And Earnings Beat At Materion (MTRN) Has Changed Its Investment Story

In the first quarter of 2026, Materion Corporation reported sales of US$549.82 million and net income of US$19.37 million, with earnings per share rising year over year and both revenue and earnings surpassing analyst estimates. Record profitability in Electronic Materials and Precision Optics, together with Materion’s highest-ever order backlog across aerospace, defense, semiconductor, and AI-related markets, highlighted how recent operational improvements and resolved production issues are...
NYSE:ARES
NYSE:ARESCapital Markets

Ares Management (ARES) Q1 2026 Margin Compression Challenges Bullish Growth Narrative

Ares Management Q1 2026 Earnings Snapshot Ares Management (ARES) has opened 2026 earnings season with Q1 results that sit against a backdrop of trailing 12 month revenue of about US$5.6 billion and basic EPS of US$2.16, alongside net income of roughly US$468.7 million. Over the past year, revenue has stepped up from about US$3.9 billion in the period ending Q4 2024 to US$5.6 billion most recently, while basic EPS has moved from US$2.38 to US$2.16. This gives investors a clearer view of how...
NYSE:LXP
NYSE:LXPIndustrial REITs

Should LXP’s Record Pre-Leasing and Reaffirmed 2026 Guidance (LXP) Require Action From Investors?

LXP Industrial Trust reported first-quarter 2026 results showing sales of US$84.98 million and revenue of US$85.95 million, with a small net loss and reaffirmed full-year earnings guidance. Despite the weaker quarterly profit, the REIT highlighted record leasing activity, including pre-leasing a 1.2 million square foot Phoenix development to a major global logistics tenant, underscoring sustained demand for its industrial assets. We’ll now examine how this pre-leasing success and strong...
NYSE:ESRT
NYSE:ESRTOffice REITs

Empire State Building’s 95th Year Puts ESRT Tourism And ESG In Focus

Empire State Realty Trust (NYSE:ESRT) is marking the Empire State Building’s 95th anniversary with new observation deck experiences and special events. The company recently completed a US$165 million remodel aimed at improving the visitor journey and on site amenities. The building has achieved LEED v5 Platinum certification and is targeting net zero emissions for 2030, highlighting a focus on sustainability. For investors watching NYSE:ESRT, this anniversary is more than a birthday...
NYSE:GRDN
NYSE:GRDNHealthcare

Is It Too Late To Consider Guardian Pharmacy Services (GRDN) After Its 45% One Year Rally?

If you are wondering whether Guardian Pharmacy Services at US$37.37 still offers value after a strong run, the next sections will walk through what the current price could be implying. The stock has slipped 0.5% over the last 7 days and 1.6% over the last 30 days, yet it is still up 26.5% year to date and 44.9% over the past year, which may have shifted how some investors view its risk and reward trade off. Recent attention on Guardian Pharmacy Services has largely centered on its role...
NasdaqGS:MCHB
NasdaqGS:MCHBBanks

Assessing Mechanics Bancorp (MCHB) Valuation After Recent Share Price Moves

Why Mechanics Bancorp (MCHB) is on investors’ radar Mechanics Bancorp (MCHB) has attracted fresh attention after recent share price moves, with the stock up about 1% over the past day but slightly lower over the past week and past 3 months. See our latest analysis for Mechanics Bancorp. While the share price has eased over the past week and quarter, the 1-year total shareholder return of 70.51% and 5-year total shareholder return of 166.71% indicate strong momentum over a longer horizon...
NYSE:CVNA
NYSE:CVNASpecialty Retail

Is It Too Late To Reassess Carvana (CVNA) After Its Sharp Multi Year Rally?

If you are wondering whether Carvana's current share price lines up with its underlying value, this breakdown will help you connect the recent moves in the stock to what the numbers actually say. Carvana recently closed at US$382.60, with returns of 21.9% over 30 days, a 6.5% decline over 7 days, a 4.4% decline year to date, and a 48.8% return over 1 year. The 3 year return is very large. Recent news coverage has focused on Carvana's position in online used car retailing and the market's...
NYSE:OGE
NYSE:OGEElectric Utilities

The Bull Case For OGE Energy (OGE) Could Change Following New Google Data Center Power Deals

OGE Energy Corp. has already reported first-quarter 2026 earnings, with revenue of US$752.6 million and net income of US$50.2 million, while reaffirming full‑year earnings guidance of US$2.38 to US$2.48 per share. OG&E also announced long-term agreements to power three new Google data centers in Oklahoma, with Google covering all grid-connection and contracted costs and supporting new solar projects and a proposed large‑load tariff to shield existing customers. We’ll now examine how the...
NasdaqGS:FTRE
NasdaqGS:FTRELife Sciences

Do Fortrea Holdings' (FTRE) Shrinking Sales Reveal Deeper Strains In Its Growth Strategy?

Fortrea Holdings Inc., a contract research organization spun off from Labcorp in 2023, has recently reported that its sales have declined by an average 2.9% each year over the past four years, alongside returns on capital that remain below zero. This combination of contracting revenue and ineffective investment decisions suggests earlier profit pools are shrinking and raises fresh questions about the company’s ability to execute its growth plans. Against this backdrop of multi‑year sales...
NYSE:DQ
NYSE:DQSemiconductor

Is Daqo New Energy (DQ) Pricing Look Attractive After Recent Share Price Slide

If you are wondering whether Daqo New Energy's current share price reflects its true worth, it helps to start with how the market has been treating the stock lately. The shares last closed at US$19.14, with returns of a 16.7% decline over 7 days, a 9.3% decline over 30 days, and a 35.5% decline year to date, contrasted with a 48.5% gain over the past year and larger declines of 57.2% and 74.4% over 3 and 5 years. These moves have played out against a backdrop of ongoing interest in the solar...
NasdaqGS:LASR
NasdaqGS:LASRElectronic

Is It Too Late To Consider nLIGHT (LASR) After Its Surging Share Price This Year?

For readers wondering whether nLIGHT's share price still reflects fair value after a major run-up, this article breaks down what the current price could imply about the business and its risks. Over the past week the stock has declined 6.3%, but it shows an 18.1% return over 30 days and an 85.0% return year to date, with the 1-year move sitting at roughly 7x. Recent coverage has focused on nLIGHT's position in the broader tech sector and how sentiment around high-growth, higher-risk names has...
NYSE:BW
NYSE:BWElectrical

Babcock And Wilcox Faces Contract Scrutiny And Governance Risks For Investors

Short-seller report challenges the legitimacy of Babcock & Wilcox Enterprises' purported $2.4b contract and raises concerns about undisclosed related-party links. Securities fraud class action lawsuits have been filed, alleging failures in disclosure and questioning the integrity of the company’s contract reporting. These governance and disclosure issues are drawing attention to the risks around large power generation deals and potential impact on shareholder confidence. Babcock & Wilcox...
NasdaqGS:ACAD
NasdaqGS:ACADBiotechs

Acadia R&D Chief Plans Retirement As Company Stresses Pipeline Continuity

Acadia Pharmaceuticals (NasdaqGS:ACAD) announced the planned retirement of its Head of Research and Development, Dr. Elizabeth H.Z. Thompson. Dr. Thompson is expected to transition from her current role and remain with the company as a consultant through at least the end of 2026. Her consulting role is intended to support continuity around a key Phase 2 clinical readout in Alzheimer's disease psychosis and early Phase 3 planning. Acadia focuses on central nervous system conditions, where...
NasdaqGS:SRPT
NasdaqGS:SRPTBiotechs

Do Sarepta Therapeutics’ (SRPT) Bullish Earnings Forecasts and Vanguard Stake Hint at a Shifting Risk Profile?

In recent days, Sarepta Therapeutics drew attention as Wall Street analysts projected a year-over-year earnings increase despite lower revenues for its upcoming 6 May earnings report, while a Schedule 13G filing showed Vanguard Capital Management holding a 5.11% passive stake. This combination of more bullish earnings expectations and confirmation of meaningful passive institutional ownership highlights how sentiment and ownership structure may be shaping views on Sarepta’s outlook. We’ll...
NYSE:XPEV
NYSE:XPEVAuto

Is XPeng (NYSE:XPEV) Now Fairly Priced After Recent Share Price Weakness?

Wondering whether XPeng's current share price lines up with its underlying worth, or if the market is mispricing the story? This article breaks down what the numbers actually say. XPeng recently closed at US$15.83, with returns of a 5.0% decline over 7 days, a 10.6% decline over 30 days, a 22.5% decline year to date, a 19.9% decline over 1 year, a 52.2% gain over 3 years, and a 40.7% decline over 5 years, a mixed picture that raises questions about where value really sits today. These swings...
NYSE:BIPC
NYSE:BIPCGas Utilities

Brookfield Infrastructure (BIPC) Is Down 8.5% After Mixed Q1 Results and Capital Recycling Update – What's Changed

Brookfield Infrastructure Corporation reported first-quarter 2026 results showing sales of US$884 million versus US$929 million a year earlier, and a net loss of US$112 million compared with prior-year net income of US$389 million, while affirming a quarterly dividend of US$0.4550 per share payable on June 30, 2026. Beneath the weaker accounting earnings, management highlighted a 10% increase in funds from operations, progress toward about US$1 billion of capital recycling, and a 6% dividend...
NYSE:GENI
NYSE:GENIHospitality

Is It Time To Revisit Genius Sports (GENI) After This Year’s Sharp Share Price Slide?

If you are wondering whether Genius Sports at US$4.35 is a bargain or a value trap, the starting point is to understand what the current share price is really pricing in. The stock has seen a 2.7% decline over the last week, a 4.6% decline over the last month and a 59.6% decline year to date, while the 1 year return is a 60.6% loss and the 5 year return is a 76.8% loss, with only the 3 year period showing an 8.2% gain. These moves sit against a backdrop of ongoing attention on sports data,...
NasdaqGS:OLED
NasdaqGS:OLEDSemiconductor

Is It Time To Reassess Universal Display (OLED) After A 32% Share Price Slide?

If you are wondering whether Universal Display at around US$96 per share still offers value, the key is to look past the headline share price and focus on what different valuation lenses are saying. The stock is down about 32.0% over the last year and 20.9% year to date, even though the past month shows a 7.4% gain after a softer 2.7% move over the last week. Recent coverage has focused on Universal Display’s position in the semiconductor space and how investors are weighing its long term...
NYSE:ARMK
NYSE:ARMKHospitality

Is It Too Late To Consider Aramark (ARMK) After Strong Recent Share Price Gains?

If you are wondering whether Aramark’s current share price reflects its true value, the next sections walk through what the numbers actually say about the stock. Aramark shares last closed at US$44.95, with returns of 5.6% over 30 days, 22.9% year to date and 35.2% over 1 year, which has many investors reassessing both its potential and its risks. Over the past year Aramark has been in the spotlight as investors have tracked its performance and repositioned their expectations for the...